AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nuvalent, Inc. Director's Dealing 2022

Jan 5, 2022

30903_dirs_2022-01-05_3440f254-8583-4271-a5e3-439e46d0266d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvalent, Inc. (NUVL)
CIK: 0001861560
Period of Report: 2022-01-04

Reporting Person: Balcom Alexandra (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-04	Stock Option (Right to Buy)	$18.93	A	107000	Acquired	2032-01-04	Common Stock (107000)	Direct

Footnotes

F1: The shares underlying this option vest as follows: 25% of the shares vest on January 4, 2023, and the remainder vest over the next three years in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.